论文信息 - RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families - 字舞流文

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families

A. Meindl | R. Schmutzler | H. Hellebrand | B. Wappenschmidt | E. Hahnen | S. Engert | K. Rhiem | L. Garbes | J. Hauke | A. Becker | N. Weber-Lassalle | G. Neidhardt | Gioia Schnurbein

[1] C. Vachon,et al. Genetic susceptibility to triple-negative breast cancer. , 2013, Cancer research.

[2] Alfons Meindl,et al. Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction , 2012, PloS one.

[3] A. Meindl,et al. Germline RAD51C mutations confer susceptibility to ovarian cancer , 2012, Nature Genetics.

[4] Samantha E. Boyle,et al. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients , 2012, Hereditary Cancer in Clinical Practice.

[5] J. Schleutker,et al. RAD51C is a susceptibility gene for ovarian cancer. , 2011, Human molecular genetics.

[6] Dieter Niederacher,et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene , 2010, Nature Genetics.

[7] Marion Kee,et al. Analysis , 2004, Machine Translation.